Invitae Corp (NVTA) Files Form 4 Insider Selling : Patty Dumond Sells 3,221 Shares

Invitae Corp (NVTA): Patty Dumond , VP Fin. & Principal Acct. Off. of Invitae Corp sold 3,221 shares on May 16, 2016. The Insider selling transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were sold at $8.54 per share for a total value of $27,275.35 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 18, 2016, Patty Dumond (VP Fin. & Principal Acct. Off.) sold 1,000 shares at $10.50 per share price.On Mar 2, 2016, Lisa Alderson (Chief Strategy Officer) sold 5,000 shares at $9.05 per share price.Also, On Aug 13, 2015, Sean E George (COO) purchased 49,899 shares at $9.12 per share price.

Shares of InVitae Corp (NVTA) ended Thursday, May 19, 2016 session in red amid volatile trading. The shares closed down -0.1 points or -1.18% at $8.35 with 50,446 shares getting traded. Post opening the session at $8.18, the shares hit an intraday low of $7.99 and an intraday high of $8.39 and the price vacillated in this range throughout the day. The company has a market cap of $268 M and the number of outstanding shares has been calculated to be 3,20,53,486 shares. The 52-week high of InVitae Corp is $16.39 and the 52-week low is $5.66.

InVitae Corp Money Flow Index Chart

Invitae Corporation is a company that utilizes an integrated portfolio of laboratory processes software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples analyze information about patient-specific genetic variation and generate test reports for physicians and their patients. The Company has two laboratories: one in San Francisco California and a second in Santiago Chile. The Company’s first product is an assay of 216 genes that can be used for multiple indications. The test includes multiple genes associated with hereditary cancer neurological disorders cardiovascular disorders and other hereditary conditions. The Company also offers panels for pediatric conditions such as Noonan spectrum disorders and ciliopathies.

Leave a Reply

InVitae Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on InVitae Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.